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SUMMARY
Objective: Determination of the correlation of interleukin-1 (IL-1), IL-6, IL-8, tumor necrosis factor (TNF),
and vascular endothelial growth factor (VEGF) levels in serum and ascites with the severity of ovarian
hyperstimulation syndrome (OHSS).
Case Report: We present the case of a woman with primary infertility who was enrolled in an ovulation induction
program. OHSS developed 6 days after artificial insemination with the husband’s sperm. We performed
continuous paracentesis and recorded daily concentrations of IL-1, IL-6, IL-8, TNF, and VEGF in serum and
ascites in an attempt to determine their correlation with the severity of OHSS.
Conclusions: Improvement in symptoms and a decreasing amount of ascites were correlated with a decreasing
serum concentration of VEGF. [Taiwanese J Obstet Gynecol 2004;43(2):107–109]
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Introduction
Assisted reproductive techniques are well established
in overcoming the increasing problem of infertility.
Unfortunately, a serious and potentially life-threatening
complication, ovarian hyperstimulation syndrome
(OHSS), sometimes occurs due to ovulation induction.
The incidence of OHSS in in vitro fertilization programs
is approximately 1–10% of induced cycles [1]. Severe
forms of OHSS occur in 0.5% of patients [2]. Although
the pathophysiology of this syndrome has not been
completely elucidated, many of the clinical manifes-
tations of OHSS resemble a noninfectious systemic
inflammatory response, characterized by increased vas-
cular permeability, hypotension, and shock, progressing
to intravascular depletion, renal failure, and death.
During the last decade, several studies have repor-
ted that levels of many cytokines, including interleukin
(IL)-6, IL-8, tumor necrosis factor-α (TNF-α), and
vascular endothelial growth factor (VEGF), are cor-
related to this syndrome [3]. Whether the cytokines
are directly responsible for the clinical manifestations
or whether they are a result of the pathophysiology is
unclear. In an effort to clarify the roles of cytokines in the
development of OHSS, we recorded data on cytokine
fluctuation in blood and ascites in a patient with OHSS
during hospitalization. Treatment for OHSS is still con-
troversial, although supportive measures such as salt
and water restriction and central volume replacement
are commonly accepted. Paracentesis and thoraco-
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centesis of accumulated fluid are performed only when
the condition is life threatening. We describe a pa-
tient with OHSS who underwent paracentesis for symp-
tom relief. Furthermore, we show the daily fluctuations
of cytokines in an attempt to monitor the correlation
between the severity of the disease and the serial
concentrations of the cytokines.
Case Report
This 30-year-old woman had been married for 3 years
but had never become pregnant despite a normal sex
life. She visited our hospital where unexplained primary
infertility was diagnosed. We suggested intrauterine
insemination (IUI) as her bilateral tubes were patent.
Ovulation was induced with 100 mg oral clomiphene
daily from days 3 to 7, and two ampoules of Pergo-
nal (Serono SA, Geneva, Switzerland; 75 IU follicle-
stimulating hormone and 75 IU luteinizing hormone)
injected on days 6, 8 and 10. The IUI procedure was
carried out on day 14. The patient was admitted to
our hospital due to abdominal distension 6 days
after IUI. Initially, conservative treatment did not im-
prove symptoms, which included abdominal distension
and dyspnea due to massive ascites and growing pleu-
ral effusion. From day 6 of hospitalization, 12 days
after IUI, we inserted a continuous drainage catheter
(nephrostomy pigtail 10 Fr, 30 cm catheter) into the
peritoneal cavity using an aseptic procedure. The daily
amount drained and the cytokine levels in serum and as-
cites were recorded. The patient’s symptoms improved
as the amount of ascites drained daily decreased. She
was discharged on day 14 of hospitalization. Subse-
quently, her pregnancy was unremarkable and she had
a healthy 2,690 g female and a 2,155 g male infant by
cesarean section at 36 weeks’ gestation.
The daily amount of ascites drained and daily serum
VEGF concentrations are shown in the Figure. The
serum and ascites concentrations of IL-1 and TNF-α did
not appear to be relevant to the progression of OHSS.
There was also no correlation between the ascites
concentration of VEGF and OHSS symptoms. More
data are required to formulate a possible relationship.
Discussion
In recent decades, several reports have investigated and
confirmed the pathophysiologic changes associated
with OHSS in serum, ascites, and pleural effusion. There
is elevation of multiple cytokines, including IL-2, IL-6,
and IL-8 [1,2,4,5]. VEGF is also increased [1,3]. Most
studies used the expression of these cytokines in serum
and ascites to predict the occurrence and severity of
OHSS. One report suggested that cases of OHSS did
not require hospitalization if aggressive paracentesis
and thoracocentesis were carried out in the outpatient
department [6]. From our results, we agree that aggres-
sive treatment is beneficial. With conservative treat-
ment, patients mostly suffer from abdominal disten-
sion, oligouria, and dyspnea. It is reasonable to require
bed rest, home monitoring with intermittent outpatient
paracentesis, and adequate albumin administration.
In this case, we attempted to monitor the daily
fluctuations of a series of cytokines. IL-6 may be the
most relevant to OHSS; several reports indicate that it
is a possible factor in the mechanism of OHSS. More-
over, many investigations have observed a significant
elevation in IL-6 in serum, ascites, and plural effusion
in OHSS patients. IL-6 is produced by monocytes, en-
dothelial cells, T cells, and fibroblasts. Its production
is induced by shock-triggering cytokines such as IL-1
and TNF-α [1]. IL-6 is produced during follicular
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Figure. (A) Daily amount of ascites drained by paracentesis;
(B) daily serum concentration of vascular endothelial growth
factor (VEGF).
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neovascularization, and it has been reported to be
involved in angiogenesis and hyperpermeability [7].
It is also produced by ovarian tumor cells and may
play an important role in maintaining tumori-
genicity with tumor vessel formation, and in the
development of ascites associated with ovarian cancer
[4,8]. A role for IL-6 in normal ovarian function has
been suggested by the observation that IL-6 RNA is
produced during neovascularization or angiogenesis
during the development of ovarian follicles [4]. We
found no correlation between our patient’s daily IL-6
levels in serum and ascites and her symptoms. This
result does not support the use of IL-6 levels to predict
the occurrence and severity of OHSS.
IL-8 is also a key cytokine related to angiogenesis.
Recently, significant elevations of IL-8 in ascites have
been observed in OHSS patients, without significant
changes in serum [7]. IL-8 has also been correlated to
the development of and recovery from OHSS, but the
relationship was not significant. Our results suggest
that it is unreasonable to believe that IL-8 would be a
good predictor of the occurrence and severity of OHSS.
Conclusions cannot be drawn without further prospec-
tive investigations.
VEGF is also considered a factor in the pathogenesis
of capillary leakage in OHSS [9]. Ovulation induction
may lead to high levels of VEGF expression due to the
growth of a large number of follicles and formation
of the corpora lutea, which results in vascular leakage
[10]. High VEGF concentrations are known to increase
vascular permeability and lead to plasma extravasa-
tion followed by pronounced hemoconcentration. An
elevated VEGF concentration has been noted in the
serum and ascites of OHSS cases [9]. In addition, VEGF
plasma levels are positively correlated with OHSS [10].
In our case, the fluctuation of VEGF in serum was
obviously relevant to the volume of ascites being drained
(Figure).
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